The toxic culture of Eli Lilly

Anonymous

Guest
This can't possibly get much worse:
1. Absolute void of leadership at the top of the company.
2. Self centered backstabbers getting key positions.
3. No accountability - zero focus on results.
4. Same mistakes repeated over and over again.
5. Insular culture which shuns reality.
6. Too much focus on things that don't matter.
7. Tough decisions routinely avoided.
8. No sense of direction.
9. Poor performers allowed to hang around.
10. Lack of toughness and determination.
 






This can't possibly get much worse:
1. Absolute void of leadership at the top of the company.
2. Self centered backstabbers getting key positions.
3. No accountability - zero focus on results.
4. Same mistakes repeated over and over again.
5. Insular culture which shuns reality.
6. Too much focus on things that don't matter.
7. Tough decisions routinely avoided.
8. No sense of direction.
9. Poor performers allowed to hang around.
10. Lack of toughness and determination.

11. Top talent allowed to walk out the door or accept demeaning demotions just to stay at Lilly.
12. Canadians taking over the US marketplace.
13. No quantitative measure of individual performance. What does Wall Street think about this? As a shareholder, I hate it.
14. Poorest of performers stayed due to all the top performers leaving jobs open.
15. Brand teams thinking they can sell the product better than the reps can. E.g Axiron Brand particularly guilty of this. All if their covert attempts and pilots to prove they could sell more Axiron than the field. Inability to accept who the real testosterone pt really is. Cialis Brand thinking the ACA will continue to pay for ED meds, deluded by the fact that the BPH indication will save the brand, etc...

Please someone else jump in.
 






11. Top talent allowed to walk out the door or accept demeaning demotions just to stay at Lilly.
12. Canadians taking over the US marketplace.
13. No quantitative measure of individual performance. What does Wall Street think about this? As a shareholder, I hate it.
14. Poorest of performers stayed due to all the top performers leaving jobs open.
15. Brand teams thinking they can sell the product better than the reps can. E.g Axiron Brand particularly guilty of this. All if their covert attempts and pilots to prove they could sell more Axiron than the field. Inability to accept who the real testosterone pt really is. Cialis Brand thinking the ACA will continue to pay for ED meds, deluded by the fact that the BPH indication will save the brand, etc...

Please someone else jump in.

16. Countless hours spent on senseless six sigma projects by "top performers."
 






16. Countless hours spent on senseless six sigma projects by "top performers."

17. Far too much emphasis placed on diversity and affirmative action and too little placed on performance.
18. Inability to willingly learn from mistakes.
19. Giving the customers what they want only when it is what we wanted to do in the first place.
20. A weak board of directors who are unwilling to step up and make the necessary changes at the top.
 






17. Far too much emphasis placed on diversity and affirmative action and too little placed on performance.
18. Inability to willingly learn from mistakes.
19. Giving the customers what they want only when it is what we wanted to do in the first place.
20. A weak board of directors who are unwilling to step up and make the necessary changes at the top.

21. Indianapolis or Connecticut makes a decision, then says now, what do we tell those idiots in sales?
 


















#. Management doesn't listen to logic or technical details, only management speak and "what's hot".
#. Lost sight of what is important, to train and retain great workers.
#. Culture of "cliques" of the highest order, this places people with schmoozing skills above people with real skills.
#. The FDA environment is a mess, needs to be overhauled and useless work should be abolished.
#. Low morals of leadership encourages bad morals and becomes ingrained until the whole mess literally rots.

To the haters: If these are not spot on, then why is the company doing so poorly?
 






#.
Management doesn't listen to logic or technical details, only management speak and "what's hot".
#. Lost sight of what is important, to train and retain great workers.
#. Culture of "cliques" of the highest order, this places people with schmoozing skills above people with real skills.

So spot on! Diversity my butt hole!! Morons surrounding themselves with like minded morons - further insulating and distancing themselves from the reality of what's happening! I'm sure Lilly will snatch defeat from the jaws of victory even with new products to launch due to this toxic culture.
 


















So spot on! Diversity my butt hole!! Morons surrounding themselves with like minded morons - further insulating and distancing themselves from the reality of what's happening! I'm sure Lilly will snatch defeat from the jaws of victory even with new products to launch due to this toxic culture.

What new products to launch???
 






























Ever heard of urgency ....with the pipeline too little too late

Late, yes, too little, no.

Sure, there are a few lean years ahead but there are drugs in the pipeline that will come good. Gastric cancer and diabetes as a couple of examples of health spaces where the company has some good candidates. Lilly may become a 15 or even 10 billion a year company for a while but I doubt that it will go below that level. Sure this will hurt but there's many a company that would kill for that level of turnover.
 






Ok, but in the meantime there appears to be a very toxic environment, a lot of unhappy people and a management style that is brutal. So good people will leave in droves and yes you can always hire more good people at a later date but that's pretty cold and heartless. But I guess that's business.........right.
 






Late, yes, too little, no.

Sure, there are a few lean years ahead but there are drugs in the pipeline that will come good. Gastric cancer and diabetes as a couple of examples of health spaces where the company has some good candidates. Lilly may become a 15 or even 10 billion a year company for a while but I doubt that it will go below that level. Sure this will hurt but there's many a company that would kill for that level of turnover.

Baaahhhaaaaaa!!!!!!! No way we can survive long enough to see enough decent drugs come out. They have done nothing but stuff a bunch of crap molecules into P1 trials to try to keep Wall Street buying our worthless stock. That's the reason that we used to launch so many drugs. We didn't have nearly as many molecules in the pipeline but they were drugs that we KNEW would most likely to make it out. Now they go on TV and brag about the number of drugs in our pipeline when they KNOW that most of them are total crap. It's like Madoff's Ponzi scheme. Sooner or later it's exposed and you can't run from it any more. The scam is up. What other pharma company has had 9 total losers in such a short amount of time? They knew all along these drugs were not going to make it. They just propped them up to keep the money coming in so that they could cash in. Of course our worthless BOD has just sat there and watched it happen. Because they are hand picked by our leaders as well. What has happened to this company is CRIMINAL. How are all the stock holders feeling now that it is obvious that they have been taken for a ride?
 






Ok, but in the meantime there appears to be a very toxic environment, a lot of unhappy people and a management style that is brutal. So good people will leave in droves and yes you can always hire more good people at a later date but that's pretty cold and heartless. But I guess that's business.........right.


Mgmt is looking to get out, too. Don't kid yourself.